Literature DB >> 15708253

Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505.

Robert L Foote1, Noel Weidner, Jonathan Harris, Elizabeth Hammond, Jean E Lewis, Te Vuong, K Kian Ang, Karen K Fu.   

Abstract

PURPOSE: The objective of this study was to evaluate tumor angiogenesis as measured by microvessel density (MVD) as an independent prognostic factor in patients with nasopharyngeal carcinoma (NPC) treated with radiotherapy alone. METHODS AND MATERIALS: Eligible patients included those with NPC treated with radiotherapy. Paraffin blocks of the primary tumor had a hematoxylin and eosin-stained section prepared at the block face. One representative section for tumor was stained for factor VIII-related antigen using a standard immunoperoxidase staining technique. MVD was determined by light microscopy in areas of invasive tumor containing the highest numbers of capillaries and microvessels per area. Individual microvessel counts were made on a 200x field within the area of most intense tumor neovascularization. Results were expressed as the highest number of microvessels identified within any single 200x field. Using a breakpoint of MVD <60 vs. > or =60, the distributions between the two MVD groups were compared by the method of Gray. Overall survival rates were estimated by the Kaplan-Meier method and compared by the log-rank test. A multivariate Cox proportional hazard model was employed to examine the relationship between MVD and disease outcomes while adjusting for other concomitant variables.
RESULTS: One hundred sixty-six were eligible, of whom 123 had values determined for MVD. The MVD values ranged from 9 to 243 with a median of 70. In the multivariate analysis of overall survival, distant metastases, and local-regional failure, MVD did not significantly improve the model containing T stage, N stage, age, radiation dose, and World Health Organization class.
CONCLUSIONS: We found no significant differences in overall survival, time to distant metastasis, or time to local-regional failure using a breakpoint of MVD <60 vs. MVD > or =60. The study was perhaps limited by the small size of the NPC samples.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708253     DOI: 10.1016/j.ijrobp.2004.07.694

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  24 in total

1.  Role of Bcl-2 and its associated miRNAs in vasculogenic mimicry of hepatocellular carcinoma.

Authors:  Nan Zhao; Bao-Cun Sun; Xiu-Lan Zhao; Yong Wang; Jie Meng; Na Che; Xu-Yi Dong; Qiang Gu
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

2.  The Impact of Smoking on Gingiva: a Histopathological Study.

Authors:  Noushin Jalayer Naderi; Hassan Semyari; Zahra Elahinia
Journal:  Iran J Pathol       Date:  2015

3.  Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma.

Authors:  Edwin Pun Hui; Vivian W Y Lui; Cesar S C Wong; Brigette B Y Ma; Cecilia P Y Lau; Crystal S F Cheung; Kakiu Ho; Suk-Hang Cheng; Margaret H L Ng; Anthony T C Chan
Journal:  Invest New Drugs       Date:  2010-05-15       Impact factor: 3.850

Review 4.  Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins.

Authors:  Shuang Liu
Journal:  Bioconjug Chem       Date:  2015-08-03       Impact factor: 4.774

Review 5.  Molecular imaging in cancer treatment.

Authors:  Mark H Michalski; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-27       Impact factor: 9.236

6.  Scintigraphic Imaging of Neovascularization With 99mTc-3PRGD2 for Evaluating Early Response to Endostar Involved Therapies on Pancreatic Cancer Xenografts In Vivo.

Authors:  Xiaona Jin; Chengyan Dong; Kun Zheng; Ximin Shi; Yu Liu; Li Huo; Fan Wang; Fang Li
Journal:  Front Oncol       Date:  2021-12-15       Impact factor: 5.738

7.  Correlation of integrin beta3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinoma.

Authors:  Shu-Guang Li; Zai-Yuan Ye; Zhong-Sheng Zhao; Hou-Quan Tao; Yuan-Yu Wang; Chun-Yu Niu
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

8.  (99m)Tc-3P-RGD2 SPECT to monitor early response to bevacizumab therapy in patients with advanced non-small cell lung cancer.

Authors:  Bin Chen; Guoqing Zhao; Qingjie Ma; Bin Ji; Tiefeng Ji; Hua Xin; Shi Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

9.  A comparative evaluation of ultrasound molecular imaging, perfusion imaging, and volume measurements in evaluating response to therapy in patient-derived xenografts.

Authors:  J E Streeter; S G Herrera-Loeza; N F Neel; J J Yeh; P A Dayton
Journal:  Technol Cancer Res Treat       Date:  2013-01-25

10.  Nuclear exosome HMGB3 secreted by nasopharyngeal carcinoma cells promotes tumour metastasis by inducing angiogenesis.

Authors:  Kaiwen Zhang; Dong Liu; Jianmei Zhao; Si Shi; Xin He; Peng Da; Yiwen You; Bo You
Journal:  Cell Death Dis       Date:  2021-05-28       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.